Source: International Congress 2015 – Immunodepression and severe pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Yavuz Havlucu (Manisa, Turkey), Yavuz Havlucu, Fikret Kurhan, Timur Pirildar, Tugba Goktalay, Aysin Sakar Coskun, Pinar Celik, Arzu Yorgancioglu. Pulmonary infections in patients receiving treatment of tumor necrosis factor alpha antagonists. Eur Respir J 2015; 46: Suppl. 59, 2647

Member's Comments

No comment yet.

Related content which might interest you: Should isoniazid prophylaxis be prescribed to the patients under tumor necrosis factor-alpha antagonists independent of tuberculin skin test? Source: International Congress 2015 – Screening strategies in TB Year: 2015 Latent tuberculosis screening and entering antibody therapy monoclonares against tumor necrosis factor Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Miliary tuberculosis during treatment with anti TNF alpha - a report of four cases Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Screening and monitoring of tuberculosis in patients on tumor necrosis factor antagonist therapy Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011 Tuberculosis in patients receiving treatment of TNF-alpha inhibitors Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015 Anti-TNF-alpha therapy in patients with latent tuberculosis incidence Source: International Congress 2015 – Screening strategies in TB Year: 2015 Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients Source: International Congress 2015 – Screening strategies in TB Year: 2015 Necrosis as a predictor of infection in granulomatous lung disease Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Initiation of anti-TNF therapy within 3 weeks of LTBI treatment in patients with immune-mediated inflammatory diseases Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 Screening for latent tuberculosis before tumour necrosis factor antagonist therapy Source: Eur Respir J 2015; 45: 1510-1512 Year: 2015 Screening for latent tuberculosis before tumour necrosis factor antagonist therapy Source: Eur Respir J 2015; 45: 1512-1513 Year: 2015 TB in the immunocompromised host Source: Eur Respir Mon 2012; 58: 230-241 Year: 2012 Opportunistic infections in patients with lung tuberculosis Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015 Inhaled IFN-γ for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-γ deficiency Source: Eur Respir J 2004; 24: 367-370 Year: 2004 Clinical characteristics of pulmonary nocardiosis in immunocompetent patients Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015 Biomarkers of systemic inflammatory response in patients with tuberculosis, combined with HIV infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Expression levels of membrane-bound tumor necrosis factor alpha receptors in active tuberculosis and healthy individuals Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013